To assess the usefulness of this panel of proteins (CDH3, LFNG, and PLAU) in pancreatic cancer diagnostics, sera from pancreatic cancer patients and their kindred should be analyzed. The gene discussed is PLAU; the disease is familial pancreatic carcinoma.